Lasa Supergenerics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Lasa Supergenerics Ltd. on BSE

Load latest

Lasa Supergenerics Ltd.

26 Apr 2022

18.14

-0.55%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Attached is the copy of Press Release titled 'LASA SECURES BULK ORDER OF ? 500 MILLION' issued by the Company. You are requested to note the above on your records.

pdf

Lasa Supergenerics Ltd.

25 Apr 2022

18.14

-0.55%

Company Update

Lasa Supergenerics Ltd - 540702 - Disclosure Of Related Party Transaction Under Regulation 23(9) Of SEBI …

BSE India

Pursuant to Regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 please find enclosed herewith Disclosure of Related Party Transactions for the year ended March 31, 2022. You are requested to note the above on your records.

pdf

Lasa Supergenerics Ltd.

25 Apr 2022

18.14

-0.55%

Company Update

Lasa Supergenerics Ltd - 540702 - Format of Initial Disclosure to be made by an entity …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayLasa Supergenerics Ltd 2CINL24233MH2016PLC274202 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Ankita Shetty Designation: Company Secretary and Compliance Officer EmailId: cs@lasalabs.com Name of the Chief Financial Officer: Ravi Shankar Kabra Designation: Chief Financial Officer EmailId: raviskabra.rsk@gmail.com Date: 25/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Lasa Supergenerics Ltd.

12 Apr 2022

18.14

-0.55%

Company Update

Lasa Supergenerics Ltd - 540702 - Compliances - YEARLY CERTIFICATE FROM PRACTICING COMPANY SECRETARY UNDER REG …

BSE India

Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are enclosing herewith the certificate from Amit R. Dadheech & Associates, Practicing Company Secretary for the year ended March 31, 2022.

pdf

Lasa Supergenerics Ltd.

11 Apr 2022

18.14

-0.55%

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

LASA SUPERGENERICS PAT AT 12.35 Cr up by Robust 362% as compared to Loss of 4.71 Cr in Q3FY22

pdf

Lasa Supergenerics Ltd.

11 Apr 2022

18.14

-0.55%

Corp. Action

Lasa Supergenerics Ltd - 540702 - Corporate Action-Board approves Dividend

BSE India

Recommendation of the final Dividend of Rs 0.25 (2.5%) per equity share for the financial year ended March 31, 2022, subject to the approval of the shareholders at the ensuing General Meeting of the Company.

pdf

Lasa Supergenerics Ltd.

11 Apr 2022

18.14

-0.55%

Result

Lasa Supergenerics Ltd - 540702 - Results-Financial Results For Year Ended March 31, 2022

BSE India

Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 10.30 a.m. and concluded at 12:45 p.m. inter- alia have considered and approved the following: 1. The Audited Financial Results of the Company for the Quarter and financial Year ended March 31, 2022. 2. Recommendation of the final Dividend of Rs 0.25 (2.5%) per equity share for the financial year ended March 31, 2022, subject to the approval of the shareholders at the ensuing General Meeting of the Company.

pdf

Lasa Supergenerics Ltd.

11 Apr 2022

18.14

-0.55%

Board Meeting

Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting Held Today …

BSE India

pdf

Lasa Supergenerics Ltd.

11 Apr 2022

18.14

-0.55%

Annual Report

Annual report for Lasa Supergenerics Ltd. for FY-2022

None

pdf

Lasa Supergenerics Ltd.

08 Apr 2022

18.14

-0.55%

Company Update

Lasa Supergenerics Ltd - 540702 - Statement Of Investor Complaints For The Quarter Ended March 2022

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ankita ShettyDesignation :- Company Secretary and Compliance Officer

Is Lasa Supergenerics Ltd. worth buying?

50 Votes:

Buy 76.0%

Sell 18.0%

Hold 6.0%